Global Mismanagement of COVID-19 Pandemic Slammed in New Peer-Reviewed Paper

The UK COVID-19 Inquiry seems to be avoiding most of the fundamental questions about our response to the pandemic – such as were our actions proportionate, effective or safe and did they minimise collateral damage. Given this, it seems unlikely it will produce anything very useful, despite spending millions of pounds and years (three so far) in the effort. A recent article in these pages concurred and called for it to be stopped immediately.

So, we have to look elsewhere for constructive critical thought and answers to such questions if we are to know how to respond better next time. Fortunately, a comprehensive review of how the world responded has just been published in the International Journal of Public Health entitled ‘What lessons can be learned from the management of the COVID-19 pandemic?‘ This study is the first major independent multidisciplinary assessment of the entire pandemic response (2020-2023) and was conducted by a team of 37 co-authors (including the two of us) from 13 countries (across Europe, North America and South America).

Unlike previous assessments that focused narrowly on one or two aspects, this review uniquely integrates perspectives from many disciplines and scrutinises the major COVID-19 policies implemented globally, from initial lockdowns, mask mandates and other non-pharmaceutical interventions (NPIs) to the rollout of vaccination programmes. The authors identify significant scientific flaws underpinning many of these policies and make recommendations in four key areas.

Over-reliance on inadequately tested mathematical models

Co-author Professor Norman Fenton, a risk specialist at Queen Mary University of London, said:

Much of the Covid response was compromised by flawed definitions, mathematical models that were not grounded in rigorous testing against actual data and easily manipulated statistics. These were used to mislead and frighten the public into unnecessary and ineffective interventions, while attempts to highlight these concerns were largely censored.

The study argues that these flawed models led to misguided policies that failed to account for real-world complexities.

Recommendation 1: Models should be used as a tool to supplement, not replace empirical analysis, they should be treated with considerable scepticism, and their relevance and suitability should be continually revisited and reassessed over time.

Use of Non-Pharmaceutical Interventions

Many of the NPIs implemented during the pandemic had some justification in theory from laboratory experiments or modelling studies. However, many other studies have shown empirically that the NPIs were much less effective in the real world, or not effective at all. Furthermore, these disappointing levels of benefits were accompanied by substantial harms, many of which were predictable, and indeed had been predicted. 

Recommendation 2: If NPIs are ever to be considered again, health impact assessments that consider benefits, harms and costs are essential, as are studies to objectively assess their effectiveness over time.

Use of Pharmaceutical Interventions

Physicians exploring the potential use of promising repurposed drugs faced sanctions and media derision, while researchers raising scientific or ethical concerns about the safety and effectiveness of rapidly adopted gene-based vaccines were dismissed, despite increasing reports of adverse reactions. Lead author Dr Gerry Quinn, a microbiologist and immunologist, talking about the MHRA Yellow Card system emphasised: “The ‘safety signal’ system was originally created to serve as an early warning system against medical disasters. It is very disconcerting that the alarm bells from this system have been ringing since 2021, yet no-one seems to care. This raises serious ethical concerns.”

Recommendation 3: Research into the development of potential treatments using generic repurposed drugs with well-established safety profiles should have been encouraged rather than discouraged. We should ensure that responses to future pandemics will welcome rather than oppose such research.

Recommendation 4: Researchers should be encouraged to critically evaluate claims that a particular vaccine is safe and effective without the fear of potentially being labelled as anti-vax or anti-science if their research findings reveal any negative results.

Recommendation 5: Future vaccination programmes should involve a more thorough evaluation of the safety and effectiveness of the vaccines in relevant subgroups; if still deemed necessary, programmes should be based on fully informed and voluntary consent.

Recommendation 6: Hippocrates proposed that the combating of disease should involve an individual collaboration between physician and patient. While pharmaceutical companies produce products for mass usage and national health services often design policies at a national level, it is of paramount importance that patients and physicians are allowed to work together to develop personal healthcare pathways designed for the circumstances of each individual patient.

The suppression of valid scientific perspectives when addressing mis-information

In a misguided attempt to reduce ‘the spread of misinformation’, media outlets, social media platforms, government agencies and scientific journals have severely restricted access to valuable scientific information and severely hampered informed discussion of complex, multifaceted problems associated with COVID-19.

Recommendation 7: The best antidote to bad ideas is to counter them with better ideas. Censorship of different scientific opinions does not lead to better scientific opinions – it leads to weaker scientific conclusions. Scientific freedom should be cherished. If not, the costs to humanity may be very high.

This is a thoughtful and well referenced review of our management of the COVID-19 pandemic that highlights many lessons to help us prepare for the next pandemic, and is worth reading in full.

Dr Alan Mordue is a retired consultant in public health medicine and Dr Greta Mushet is a retired consultant psychiatrist and psychotherapist.